Navigation Links
Assay Designs(TM), Inc. Announces Release of First Available Product for Multiplex Analysis of Heat Shock Proteins
Date:6/1/2009

ANN ARBOR, Mich., June 1 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life science and translational research markets, has announced the release of the first commercially available multiplex assay dedicated to the analysis of heat shock proteins and molecular chaperones, the MultiBead(TM)* HSP/Chaperone 8-Plex Kit.

The bead-based multiplex immunoassay enables measurement of HSP client proteins (Akt and Akt phosphor-Ser473) and HSPs (Hsp27 phospho Ser15, Hsp27 phospho-Ser82, Hsp40, Hsp60, Hsp70 and Hsp90 alpha) in cell lysates. The assay utilizes monoclonal antibodies or antigen affinity purified polyclonal antibodies covalently coupled to latex beads. The detection antibodies are conjugated to biotin followed by a streptavidin-PE conjugate and analyzed on a dual-laser flow cytometer. The HSP/Chaperone panel provides a sensitive, rapid and specific method for accurately determining analyte levels in cell lysates.

"This new multiplex research tool builds on our core competency as a leader in cellular stress research, which was solidified with our acquisition of Stressgen Bioreagents in 2005," stated Mike Vespremi, Product Manager for Assay Designs. "Building on that expertise we've created a multiplex panel with specific benefits for many of our core customers where one had not previously existed."

The MultiBead technology, which already has products for inflammatory markers, is a major focus for Assay Designs research and development department and several additional panels are expected to launch this calendar year.

Additionally, Assay Designs has made available a complete update of the MultiBead Analysis Software in releasing version 2.0. This newest iteration of the MultiBead software has a more intuitive and graphical interface which complements additional features including the usage of dot-density scatter plots, the ability to change and recalculate experimental parameters in real time, and more extensive result reporting with customizable data output. The new software package also allows the user to create experimental templates for streamlining analysis of similar experiments, as well as the ability to save progress at defined points in the analysis so it can be completed or recalculated at another time. MultiBead Analysis Software v2.0 (PC and Mac versions) is available for download at no charge to customers from the Assay Designs website.

About Assay Designs, Inc. (now an Enzo Life Sciences company)

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the Assay Designs and Stressgen(R) brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress. New assay platforms include MultiBead(TM)* bead-based multiplex immunoassay kits and ImmunoSet(TM) ELISA development reagents.

*MultiBead is Reg. U.S. Pat. & TM. Office

www.assaydesigns.com


'/>"/>
SOURCE Assay Designs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform
2. AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1
3. BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
4. Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay
5. Polycystic Kidney Disease Assay at Cornell University Uses Transgenomics Surveyor Nuclease & WAVE Technology
6. Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
7. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
8. Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
9. SAFC Pharma Augments Assay Development Capabilities
10. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
11. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... ... of human cardiovascular cells for research and the development of cardiac regeneration ... to generate large numbers of cardiomyocytes (hPSC-CMs). Due to varying differentiation efficiencies, ...
(Date:5/23/2017)... ... 2017 , ... Vortex Biosciences , provider of circulating tumor cell (CTC) ... cells using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. ... Carlo and Dr. Matthew Rettig at the University of California, Los Angeles. The publication ...
(Date:5/23/2017)... Massachusetts (PRWEB) , ... May 23, 2017 , ... ... making a splash at this year’s Bio-IT World Conference and Expo in ... Smart Data Lake® 4.0 solution. The Anzo Smart Data Lake is also a ...
(Date:5/22/2017)... ... 2017 , ... Cancer diagnostics and pathology workflow solution provider ... Association for Pathology Informatics Annual Summit at the Wyndham Grand Hotel ... Diagnostic Cockpit and Consultation Portal, Inspirata will present research it led to help ...
Breaking Biology Technology:
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited the ... the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... largest German biometrics company the two government leaders could see the three ... as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
Breaking Biology News(10 mins):